Sort
48,018 grants matching “immunotherapy”
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Liquid biopsy in myeloma to inform outcome and treatment decisions
$407,175Jens G Lohr · Dana-Farber Cancer Inst · R37 · FY2023 · CA
RNA-Based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$407,160John H Sampson · Duke University · R01 · FY2009 · CA
ChAllenging to Foods with Escalating ThrEsholds for ReducIng Food Allergy
$407,142Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$407,082Xiumei Huang · Indiana University Indianapolis · R01 · FY2021 · CA
Project 1 Melnick
$407,046Ari M. Melnick · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · CA
Phase I Clinical Trials of Novel Agents
$407,039Sloan-Kettering Institute For Cancer Res · U01 · FY2005 · CA
Proposal as a Clinical Center for Treatment
$407,034Children'S Hospital Los Angeles · U01 · FY2002 · DK
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2021 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2019 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,023Sidi Chen · Yale University · R33 · FY2020 · CA
Controlled Release of Macromolecules
$407,004Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2008 · EB
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$406,978Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$406,978Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
METABOLIC OLIGOSACCHARIDE ENGINEERING
$406,953Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2006 · GM
Clinical Scholars Biomedical Research Training Program
$406,933Ping Chi · Sloan-Kettering Inst Can Research · T32 · FY2021 · CA
METABOLIC OLIGOSACCHARIDE ENGINEERING
$406,924Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2007 · GM
Immunotherapy for Renal Cell Carcinoma
$406,901Marc S Ernstoff · Dartmouth College · R01 · FY2010 · CA
METABOLIC OLIGOSACCHARIDE ENGINEERING
$406,887Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2008 · GM
Identification of cancer neoepitope-specific T cells using novel high-throughput hydrogel based platforms
$406,871Jonathan P Schneck · Johns Hopkins University · R33 · FY2025 · CA
Pro-inflammatory T-regulatory Cells in Colon Cancer
$406,863Khashayarsha Khazaie · Mayo Clinic Rochester · R01 · FY2015 · CA
Collagen Binding MSCRAMMs
$406,859Texas A&M University Health Science Ctr · R01 · FY2001 · AR
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
$406,855Wendell A Lim · University Of California, San Francisco · R01 · FY2023 · CA